These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28927551)

  • 1. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
    Gill KM; Miller SA; Grace AA
    Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
    Gomes FV; Guimarães FS; Grace AA
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divergent activation of ventromedial and ventrolateral dopamine systems in animal models of amphetamine sensitization and schizophrenia.
    Lodge DJ; Grace AA
    Int J Neuropsychopharmacol; 2012 Feb; 15(1):69-76. PubMed ID: 21329556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel α5GABA(A)R-positive allosteric modulator reverses hyperactivation of the dopamine system in the MAM model of schizophrenia.
    Gill KM; Lodge DJ; Cook JM; Aras S; Grace AA
    Neuropsychopharmacology; 2011 Aug; 36(9):1903-11. PubMed ID: 21562483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripubertal diazepam administration prevents the emergence of dopamine system hyperresponsivity in the MAM developmental disruption model of schizophrenia.
    Du Y; Grace AA
    Neuropsychopharmacology; 2013 Sep; 38(10):1881-8. PubMed ID: 23612434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia.
    Moore H; Jentsch JD; Ghajarnia M; Geyer MA; Grace AA
    Biol Psychiatry; 2006 Aug; 60(3):253-64. PubMed ID: 16581031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vagal nerve stimulation reverses aberrant dopamine system function in the methylazoxymethanol acetate rodent model of schizophrenia.
    Perez SM; Carreno FR; Frazer A; Lodge DJ
    J Neurosci; 2014 Jul; 34(28):9261-7. PubMed ID: 25009259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAM (E17) rodent developmental model of neuropsychiatric disease: disruptions in learning and dysregulation of nucleus accumbens dopamine release, but spared executive function.
    Howe WM; Tierney PL; Young DA; Oomen C; Kozak R
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4113-27. PubMed ID: 25963563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant high frequency oscillations recorded in the rat nucleus accumbens in the methylazoxymethanol acetate neurodevelopmental model of schizophrenia.
    Goda SA; Olszewski M; Piasecka J; Rejniak K; Whittington MA; Kasicki S; Hunt MJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Aug; 61():44-51. PubMed ID: 25862088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amygdala Hyperactivity in MAM Model of Schizophrenia is Normalized by Peripubertal Diazepam Administration.
    Du Y; Grace AA
    Neuropsychopharmacology; 2016 Sep; 41(10):2455-62. PubMed ID: 27000940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal deep brain stimulation reverses physiological and behavioural deficits in a rodent model of schizophrenia.
    Perez SM; Shah A; Asher A; Lodge DJ
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1331-9. PubMed ID: 23190686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.
    Lodge DJ; Grace AA
    J Neurosci; 2007 Oct; 27(42):11424-30. PubMed ID: 17942737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. State-dependent effects of the D
    Sonnenschein SF; Gill KM; Grace AA
    Neuropsychopharmacology; 2019 Feb; 44(3):572-580. PubMed ID: 30267014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia.
    Ruda-Kucerova J; Babinska Z; Stark T; Micale V
    Neurotox Res; 2017 Jul; 32(1):121-133. PubMed ID: 28421529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.
    Sonnenschein SF; Grace AA
    Neuropharmacology; 2020 Feb; 163():107632. PubMed ID: 31077730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia.
    Perez SM; Aguilar DD; Neary JL; Carless MA; Giuffrida A; Lodge DJ
    Neuropsychopharmacology; 2016 Jan; 41(2):477-86. PubMed ID: 26068729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An augmented dopamine system function is present prior to puberty in the methylazoxymethanol acetate rodent model of schizophrenia.
    Chen L; Perez SM; Lodge DJ
    Dev Neurobiol; 2014 Sep; 74(9):907-17. PubMed ID: 24554310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal MAM treatment altered fear conditioning following social isolation: Relevance to schizophrenia.
    Bilecki W; Latusz J; Gawlińska K; Chmelova M; Maćkowiak M
    Behav Brain Res; 2021 May; 406():113231. PubMed ID: 33737089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine Administration Normalizes Behavioral and Neurophysiological Perturbations in the MAM Rodent Model of Schizophrenia.
    Weeks JJ; Grace AA; Sved AF
    Int J Neuropsychopharmacol; 2021 Dec; 24(12):979-987. PubMed ID: 34622270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.